Document ID: chunk:federal_register_of_legislation:F2024C00210:reg:9:p1
Version: federal_register_of_legislation:F2024C00210
Segment Type: reg
Provision Reference: reg 9 (pt 1/2)
Character Range: 5722–8810

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting Hodgkin lymphoma or death from Hodgkin lymphoma with the circumstances of a person's relevant service:
(1)          having smoked tobacco products:
(a)          in an amount of at least 10 pack-years before the clinical onset of Hodgkin lymphoma; and
(b)          commencing at least 5 years before the clinical onset of Hodgkin lymphoma; and
         if smoking has ceased before the clinical onset of Hodgkin lymphoma, then that onset occurred within 10 years of cessation;
            Note: one pack-year is defined in the Schedule 1 - Dictionary.
(2)          being obese for at least 5 years within the 20 years before the clinical onset of Hodgkin lymphoma;
Note: being obese is defined in the Schedule 1 - Dictionary.
(3)          having infection with human immunodeficiency virus before the clinical onset of Hodgkin lymphoma;
(4)          having serological evidence of infection with Epstein-Barr virus before the clinical onset of Hodgkin lymphoma;
(5)          having an autoimmune disease from the specified list of autoimmune diseases before the clinical onset of Hodgkin lymphoma;
Note: specified list of autoimmune diseases is defined in the Schedule 1 - Dictionary.
(6)          having received a stem cell, bone marrow or solid organ transplantation before the clinical onset of Hodgkin lymphoma;
(7)          having mature B-cell lymphoid leukaemia/small lymphocytic lymphoma at the time of the clinical onset of Hodgkin lymphoma;
Note: Mature B-cell lymphoid leukaemia/small lymphocytic lymphoma are also known as mature B-cell lymphoid leukaemia and small lymphocytic lymphoma, and chronic lymphocytic leukaemia/small lymphocytic lymphoma.
(8)          inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD):
(a)          for a cumulative period of at least 1,000 hours, within a consecutive period of 10 years, before the clinical onset of Hodgkin lymphoma; and
(b)          where the first exposure occurred at least 5 years before the clinical onset of Hodgkin lymphoma;
Note: inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) is defined in the Schedule 1 – Dictionary.
(9)          being:
(a)          on land in Vietnam; or
(b)          at sea in Vietnamese waters; or
(c)          on board a vessel and consuming potable water supplied on that vessel, when the water supply had been produced by evaporative distillation of estuarine Vietnamese waters,
         for a cumulative period of at least 30 days, at least 5 years before the clinical onset of Hodgkin lymphoma;
Note: being: (a) on land in Vietnam; or (b) at sea in Vietnamese waters; and estuarine Vietnamese waters and potable water are defined in the Schedule 1 – Dictionary.
(10)      having an active tuberculosis disease before the clinical onset of Hodgkin